MIMEDX to Host Second Quarter 2025 Operating and Financial Results Conference Call on July 30
MIMEDX (NASDAQ: MDXG) has scheduled its second quarter 2025 earnings conference call for July 30, 2025. The company will release its Q2 2025 operating and financial results after market close, followed by a management-hosted webcast and conference call at 4:30 p.m. Eastern Time.
Investors can access the call through the webcast or by phone using dedicated U.S. (877-407-6184) and international (201-389-0877) numbers with conference ID 13754722. A replay will be available on the company's website for approximately 30 days after the event.
MIMEDX (NASDAQ: MDXG) ha programmato la conference call per la presentazione dei risultati del secondo trimestre 2025 per il 30 luglio 2025. La società pubblicherà i risultati operativi e finanziari del Q2 2025 dopo la chiusura del mercato, seguiti da una webcast e una conference call condotte dal management alle 16:30 ora della costa orientale.
Gli investitori potranno partecipare alla chiamata tramite webcast o telefonicamente utilizzando i numeri dedicati per gli Stati Uniti (877-407-6184) e per l’internazionale (201-389-0877) con ID conferenza 13754722. La registrazione sarà disponibile sul sito web dell’azienda per circa 30 giorni dopo l’evento.
MIMEDX (NASDAQ: MDXG) ha programado su llamada de conferencia para los resultados del segundo trimestre de 2025 el 30 de julio de 2025. La empresa publicará sus resultados operativos y financieros del Q2 2025 después del cierre del mercado, seguida de una transmisión web y llamada de conferencia dirigida por la gerencia a las 4:30 p.m., hora del Este.
Los inversores pueden acceder a la llamada a través de la transmisión web o por teléfono usando los números dedicados para EE. UU. (877-407-6184) e internacionales (201-389-0877) con ID de conferencia 13754722. Una repetición estará disponible en el sitio web de la empresa por aproximadamente 30 días tras el evento.
MIMEDX (NASDAQ: MDXG)는 2025년 2분기 실적 컨퍼런스 콜을 2025년 7월 30일로 예정했습니다. 회사는 시장 마감 후 2025년 2분기 운영 및 재무 결과를 발표하며, 이어서 경영진 주최 웹캐스트 및 컨퍼런스 콜이 동부 표준시 오후 4시 30분에 진행됩니다.
투자자들은 웹캐스트를 통해 또는 미국 전용 번호(877-407-6184)와 국제 번호(201-389-0877)를 사용하여 컨퍼런스 ID 13754722로 전화 접속할 수 있습니다. 이벤트 후 약 30일간 회사 웹사이트에서 다시보기가 제공됩니다.
MIMEDX (NASDAQ : MDXG) a programmé sa conférence téléphonique pour les résultats du deuxième trimestre 2025 le 30 juillet 2025. La société publiera ses résultats opérationnels et financiers du T2 2025 après la clôture du marché, suivis d’un webcast et d’une conférence téléphonique animés par la direction à 16h30, heure de l’Est.
Les investisseurs peuvent accéder à l’appel via le webcast ou par téléphone en utilisant les numéros dédiés aux États-Unis (877-407-6184) et internationaux (201-389-0877) avec l’ID de conférence 13754722. Une rediffusion sera disponible sur le site internet de la société pendant environ 30 jours après l’événement.
MIMEDX (NASDAQ: MDXG) hat seine Telefonkonferenz für die Ergebnisse des zweiten Quartals 2025 für den 30. Juli 2025 angesetzt. Das Unternehmen wird seine operativen und finanziellen Ergebnisse für Q2 2025 nach Börsenschluss veröffentlichen, gefolgt von einem von der Geschäftsleitung moderierten Webcast und einer Telefonkonferenz um 16:30 Uhr Eastern Time.
Investoren können über den Webcast oder telefonisch unter den speziellen US-Nummern (877-407-6184) und internationalen Nummern (201-389-0877) mit der Konferenz-ID 13754722 teilnehmen. Eine Aufzeichnung wird etwa 30 Tage nach der Veranstaltung auf der Unternehmenswebsite verfügbar sein.
- None.
- None.
MARIETTA, Ga., July 16, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the second quarter ended June 30, 2025 after the market close on Wednesday, July 30, 2025. The MIMEDX senior management team will host a webcast and conference call to review its results beginning at 4:30 p.m. Eastern Time on the same day.
The conference call can be accessed using the following information:
Webcast: Click here
U.S. Investors: 877-407-6184
International Investors: 201-389-0877
Conference ID: 13754722
A replay of the webcast will be available for approximately 30 days on the Company’s website at www.mimedx.com following the conclusion of the event.
About MIMEDX
MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.
Contact:
Matt Notarianni
Investor Relations
470-304-7291
mnotarianni@mimedx.com
FAQ
When will MIMEDX (MDXG) report Q2 2025 earnings?
How can investors access MIMEDX's Q2 2025 earnings call?
Will there be a replay available of MIMEDX's Q2 2025 earnings call?
What time is MIMEDX's Q2 2025 earnings conference call?
